Cargando…
New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer
Aspirin (ASA) has attracted wide interest of numerous scientists worldwide thanks to its chemopreventive and chemotherapeutic effects, particularly in colorectal cancer (CRC). Incorporation of selenium (Se) atom into ASA has greatly increased their anti-tumoral efficacy in CRC compared with the orga...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730823/ https://www.ncbi.nlm.nih.gov/pubmed/33260948 http://dx.doi.org/10.3390/ijms21239017 |
_version_ | 1783621773039763456 |
---|---|
author | Ruberte, Ana Carolina González-Gaitano, Gustavo Sharma, Arun K. Aydillo, Carlos Encío, Ignacio Sanmartín, Carmen Plano, Daniel |
author_facet | Ruberte, Ana Carolina González-Gaitano, Gustavo Sharma, Arun K. Aydillo, Carlos Encío, Ignacio Sanmartín, Carmen Plano, Daniel |
author_sort | Ruberte, Ana Carolina |
collection | PubMed |
description | Aspirin (ASA) has attracted wide interest of numerous scientists worldwide thanks to its chemopreventive and chemotherapeutic effects, particularly in colorectal cancer (CRC). Incorporation of selenium (Se) atom into ASA has greatly increased their anti-tumoral efficacy in CRC compared with the organic counterparts without the Se functionality, such as the promising antitumoral methylseleno-ASA analog (1a). Nevertheless, the efficacy of compound 1a in cancer cells is compromised due to its poor solubility and volatile nature. Thus, 1a has been formulated with native α-, β- and γ-cyclodextrin (CD), a modified β-CD (hydroxypropyl β-CD, HP-β-CD) and Pluronic F127, all of them non-toxic, biodegradable and FDA approved. Water solubility of 1a is enhanced with β- and HP- β-CDs and Pluronic F127. Compound 1a forms inclusion complexes with the CDs and was incorporated in the hydrophobic core of the F127 micelles. Herein, we evaluated the cytotoxic potential of 1a, alone or formulated with β- and HP- β-CDs or Pluronic F127, against CRC cells. Remarkably, 1a formulations demonstrated more sustained antitumoral activity toward CRC cells. Hence, β-CD, HP-β-CD and Pluronic F127 might be excellent vehicles to improve pharmacological properties of organoselenium compounds with solubility issues and volatile nature. |
format | Online Article Text |
id | pubmed-7730823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77308232020-12-12 New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer Ruberte, Ana Carolina González-Gaitano, Gustavo Sharma, Arun K. Aydillo, Carlos Encío, Ignacio Sanmartín, Carmen Plano, Daniel Int J Mol Sci Article Aspirin (ASA) has attracted wide interest of numerous scientists worldwide thanks to its chemopreventive and chemotherapeutic effects, particularly in colorectal cancer (CRC). Incorporation of selenium (Se) atom into ASA has greatly increased their anti-tumoral efficacy in CRC compared with the organic counterparts without the Se functionality, such as the promising antitumoral methylseleno-ASA analog (1a). Nevertheless, the efficacy of compound 1a in cancer cells is compromised due to its poor solubility and volatile nature. Thus, 1a has been formulated with native α-, β- and γ-cyclodextrin (CD), a modified β-CD (hydroxypropyl β-CD, HP-β-CD) and Pluronic F127, all of them non-toxic, biodegradable and FDA approved. Water solubility of 1a is enhanced with β- and HP- β-CDs and Pluronic F127. Compound 1a forms inclusion complexes with the CDs and was incorporated in the hydrophobic core of the F127 micelles. Herein, we evaluated the cytotoxic potential of 1a, alone or formulated with β- and HP- β-CDs or Pluronic F127, against CRC cells. Remarkably, 1a formulations demonstrated more sustained antitumoral activity toward CRC cells. Hence, β-CD, HP-β-CD and Pluronic F127 might be excellent vehicles to improve pharmacological properties of organoselenium compounds with solubility issues and volatile nature. MDPI 2020-11-27 /pmc/articles/PMC7730823/ /pubmed/33260948 http://dx.doi.org/10.3390/ijms21239017 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ruberte, Ana Carolina González-Gaitano, Gustavo Sharma, Arun K. Aydillo, Carlos Encío, Ignacio Sanmartín, Carmen Plano, Daniel New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer |
title | New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer |
title_full | New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer |
title_fullStr | New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer |
title_full_unstemmed | New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer |
title_short | New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer |
title_sort | new formulation of a methylseleno-aspirin analog with anticancer activity towards colon cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730823/ https://www.ncbi.nlm.nih.gov/pubmed/33260948 http://dx.doi.org/10.3390/ijms21239017 |
work_keys_str_mv | AT ruberteanacarolina newformulationofamethylselenoaspirinanalogwithanticanceractivitytowardscoloncancer AT gonzalezgaitanogustavo newformulationofamethylselenoaspirinanalogwithanticanceractivitytowardscoloncancer AT sharmaarunk newformulationofamethylselenoaspirinanalogwithanticanceractivitytowardscoloncancer AT aydillocarlos newformulationofamethylselenoaspirinanalogwithanticanceractivitytowardscoloncancer AT encioignacio newformulationofamethylselenoaspirinanalogwithanticanceractivitytowardscoloncancer AT sanmartincarmen newformulationofamethylselenoaspirinanalogwithanticanceractivitytowardscoloncancer AT planodaniel newformulationofamethylselenoaspirinanalogwithanticanceractivitytowardscoloncancer |